Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
orkambi 100 mg lumacaftor / 125 mg ivacaftor granulat
vertex pharmaceuticals (ch) gmbh - lumacaftorum, ivacaftorum - granulat - lumacaftorum 100 mg, ivacaftorum 125 mg, hypromellosi acetas succinas, natrii laurilsulfas, carmellosum natricum conexum, cellulosum microcristallinum, povidonum k 30 ad granulatum pro charta corresp. natrium 0.89 mg. - la mucoviscidose - synthetika
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
orkambi 150 mg lumacaftor / 188 mg ivacaftor granulat
vertex pharmaceuticals (ch) gmbh - lumacaftorum, ivacaftorum - granulat - lumacaftorum 150 mg, ivacaftorum 188 mg, hypromellosi acetas succinas, natrii laurilsulfas, carmellosum natricum conexum, cellulosum microcristallinum, povidonum k 30 ad granulatum pro charta corresp. natrium 1.34 mg. - la mucoviscidose - synthetika
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
orkambi 200 mg / 125 mg comprimés pelliculés
vertex pharmaceuticals (ch) gmbh - lumacaftorum, ivacaftorum - comprimés pelliculés - lumacaftorum 200 mg, ivacaftorum 125 mg, hypromellosi acetas succinas, natrii laurilsulfas, cellulosum microcristallinum, carmellosum natricum conexum, povidonum k 30, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, e 120, e 132, e 133, e 171, drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammonii hydroxidum, pro compresso obducto corresp. natrium 3.51 mg. - la mucoviscidose - synthetika
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
orkambi 100 mg / 125 mg comprimés pelliculés
vertex pharmaceuticals (ch) gmbh - lumacaftorum, ivacaftorum - comprimés pelliculés - lumacaftorum 100 mg, ivacaftorum 125 mg, hypromellosi acetas succinas, natrii laurilsulfas, cellulosum microcristallinum, carmellosum natricum conexum, povidonum k 30, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, e 120, e 132, e 133, e 171, drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammonii hydroxidum pro compresso obducto corresp. natrium 2.56 mg. - la mucoviscidose - synthetika
Union européenne -
français -
EMA (European Medicines Agency)
orkambi
vertex pharmaceuticals (ireland) limited - lumacaftor, l'ivacaftor - fibrose kystique - autres produits du système respiratoire - orkambi comprimés est indiqué pour le traitement de la fibrose kystique (fk) chez les patients âgés de 6 ans et plus qui sont homozygotes pour la mutation f508del du gène cftr. orkambi granules are indicated for the treatment of cystic fibrosis (cf) in children aged 1 year and older who are homozygous for the f508del mutation in the cftr gene.
Canada -
français -
Health Canada
orkambi comprimé
vertex pharmaceuticals (canada) incorporated - ivacaftor; lumacaftor - comprimé - 125mg; 200mg - ivacaftor 125mg; lumacaftor 200mg - cystic fibrosis transmembrane conductance regulator correctors
Canada -
français -
Health Canada
orkambi comprimé
vertex pharmaceuticals (canada) incorporated - ivacaftor; lumacaftor - comprimé - 125mg; 100mg - ivacaftor 125mg; lumacaftor 100mg - cystic fibrosis transmembrane conductance regulator correctors
Canada -
français -
Health Canada
orkambi granules
vertex pharmaceuticals (canada) incorporated - lumacaftor; ivacaftor - granules - 100mg; 125mg - lumacaftor 100mg; ivacaftor 125mg - cystic fibrosis transmembrane conductance regulator correctors
Canada -
français -
Health Canada
orkambi granules
vertex pharmaceuticals (canada) incorporated - lumacaftor; ivacaftor - granules - 150mg; 188mg - lumacaftor 150mg; ivacaftor 188mg - cystic fibrosis transmembrane conductance regulator correctors
Canada -
français -
Health Canada
orkambi granules
vertex pharmaceuticals (canada) incorporated - lumacaftor; ivacaftor - granules - 75mg; 94mg - lumacaftor 75mg; ivacaftor 94mg